N

Novartis

Novartis and Par settled a $30 million price-fixing lawsuit involving the blood pressure medication Exforge.

ClosedSelected statesClaim status: Closed on August 18, 2023Payout: Closed settlementNo longer claimable

About this settlement

Alleged price-fixing of Exforge medication affecting consumers in multiple U.S. states.

This settlement resolves claims that Novartis and Par engaged in a price-fixing scheme for the blood pressure medication Exforge and its generic versions. Eligible purchasers in specified states during the covered period may file claims for compensation.

Who qualifies

  • Anyone who purchased brand or generic Exforge between Sept. 21, 2012 and June 30, 2018.
  • Purchases made in the District of Columbia, Arizona, California, Florida, Hawaii, Iowa, Maine, Michigan, Minnesota, Nebraska, Nevada, New Hampshire, New Mexico, New York, North...

Closed settlement

Claim status: Closed on August 18, 2023

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon